Alterations in capillary morphology are found in mild blood pressure elevation

Journal of Hypertension

Volumn 28, Issue 11, 2010, Pages 2258-2266

  Cheng, Cynthia ^a   Daskalakis, Constantine ^b   Falkner, Bonita ^c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b Divisions of Biostatistics   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

blood vessels; capillary; essential; hypertension; microcirculation; microvascular structure; microvessels; target organ damage

Indexed keywords

ADULT; AGE; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL TONE; BORDERLINE HYPERTENSION; CAPILLARY; CAPILLARY RESISTANCE; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ETHNICITY; FEMALE; FUNCTIONAL MORPHOLOGY; GENDER; HUMAN; HYPERGLYCEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROPHOTOGRAPHY; MINIMUM FOREARM VASCULAR RESISTANCE; PARAMETER; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

EID: 77958490853     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833e113b     Document Type: Article

References (46)

1. Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, et al. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 2006; 48:397-403. (Pubitemid 44253732)
2. Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993; 88:1444-1455.
3. Waeber B, de la Sierra A, Ruilope LM. Target organ damage: how to detect it and how to treat it? J Hypertens 2009; 27 (Suppl 3): S13-S18.
4. Lockhart CJ, Hamilton PK, Quinn CE, McVeigh GE. End-organ dysfunction and cardiovascular outcomes: the role of the microcirculation. Clin Sci (Lond) 2009; 116:175-190.
5. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001; 19:921-930.
6. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage.J Hypertens 2005; 23:247-250.
7. Heagerty AM, Izzard AS. Small-artery changes in hypertension. J Hypertens 1995; 13:1560-1565.
8. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation? Hypertension 2006; 48:1012-1017.
9. Cheng C, Daskalakis C, Falkner B. Capillary rarefaction in treated and untreated hypertensive subjects. Ther Adv Cardiovasc Dis 2008; 2:79-88.
10. Cheng C, Diamond JJ, Falkner B. Functional capillary rarefaction in mild blood pressure elevation. Clin Transl Sci 2008; 1:75-79.
11. JNC 7 Express: the Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Washington, District of Columbia, USA: National Institutes of Health; 2003.
12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
13. Vasan RS, Larson M, Leip G, Evans EP, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
14. Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J,Svendsen K, et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 2002; 287:2677-2683.
15. Serne EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001; 38:238-242.
16. Bollinger A, Fagrell B, editors. Clinical capillaroscopy: a guide to its use in clinical research and practice. Lewiston, New York, USA: Hogrefe & Huber Publishers; 1990.
17. Fleiss J. The design and analysis of clinical experiments. New York, USA: Wiley; 1986.
18. Olsen MH, Wachtell K, Hermann KL, Frandsen E, Dige-Petersen H, Rokkedal J, et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am Heart J 2002; 144:530-537.
19. Schulte KL, Braun J, Meyer-Sabellek W, Wegscheider K, Gotzen R, Distler A, et al. Functional versus structural changes of forearm vascular resistance in hypertension. Hypertension 1988; 11:320-325.
20. Sivertsson R. The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand Suppl 1970; 343:1-56.
21. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 Suppl 1:S62-S69.
22. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
23. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002; 13:1034-1039.
24. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999; 34:655-658.
25. Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica E. l Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 2006; 19:477-483.
26. Nunnally J, Bernstein I. Psychometric theory, 3rd ed. New York, New York, USA: McGraw-Hill; 1994.
27. Reading MA. Chapter 5. In: Lord FM, Novick MR, editors. Statistical theories of mental test scores. Reading, Massachusetts, USA: Addison-Welsley; 1968.
28. Maricq HR. Wide-field capillary microscopy. Arthritis Rheum 1981; 24:1159-1165.
29. Kabasakal Y, Elvins DM, Ring EF, McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55:507-512.
30. Landau J, Davis E. Capillary thinning and high capillary blood-pressure in hypertension. Lancet 1957; 272:1327-1330.
31. Duprez D, De Buyzere M, De Backer T, Vercammen J, Brusselmans F, Clement DL. Impaired microcirculation in mild-to-moderate essential arterial hypertension. J Hypertens 1992; 10:251-254.
32. Rouen LR, Terry EN, Doft BH, Clauss RH, Redisch W. Classification and measurement of surface microvessels in man. Microvasc Res 1972; 4:285-292.
33. Norris AS, Chowning JR. Capillary morphology of the nailfold in the mentally ill. J Neuropsychiatr 1964; 5:225-234.
34. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986; 13:556-563.
35. Jones BF, Oral M, Morris CW, Ring EF. A proposed taxonomy for nailfold capillaries based on their morphology. IEEE Trans Med Imaging 2001; 20:333-341.
36. Dinc A, Melikoglu M, Korkmaz C, Fresko I, Ozdogan H, Yazici H. Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol 2001; 19:S42-S44.
37. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235.
38. Cohn J. Is it the blood pressure or the blood vessel? J Am Soc Hypertens 2007; 1:5-16.
39. Smith W, Wang JJ, Wong TY, Rochtchina E, Klein R, Leeder SR, et al. Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the Blue Mountains Eye Study. Hypertension 2004; 44:442-447.
40. Witt N, Wong TY, Hughes AD, Chaturvedi NM, Klein BE, Evans R, et al. Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension 2006; 47:975-981.
41. Wang JJ, Mitchell P, Leung H, Rochtchina E, Wong TY, Klein R. Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study. Hypertension 2003; 42:534-541.
42. Holowatz LA, Thompson-Torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 2008; 105:370-372.
43. Williams SA, Boolell M, MacGregor GA, Smaje LH, Wasserman SM, Tooke JE. Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci (Lond) 1990; 79:5-8.
44. Li JS, Schiffrin EL. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1996; 28:68-74.
45. Sax FL, Cannon RO 3rd, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? NEnglJMed 1987; 317:1366-1370.
46. Khan F, Patterson D, Belch JJ, Hirata K, Lang CC. Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin Sci (Lond) 2008; 115:295-300.